ALFA FinderNSE filing, NSE: SAKAR. Summary written from the filing by ALFA Finder's alert engine.
Sakar Healthcare Ltd: key numbers
- Share price
- ₹1,083.70
- Market cap
- ₹2,411 Cr
- Revenue (annual)
- ₹251.7 Cr
- Net profit (annual)
- ₹30.48 Cr
- P/E (TTM)
- 56.2×Sector 43.8×
- Promoter holding
- 51.70%-0.82% QoQ
- FII holding
- 12.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sakar Healthcare Ltd
All →Sakar Healthcare Earnings Call Transcript: Key Takeaways
Sakar Healthcare delivered exceptional growth as its oncology segment scales, with EBITDA doubling and margins expanding significantly due to product-mix shifts. Management is pivoting from a non-oncology focus to high-margin oncology formulations and APIs.
- Call
- Guides 35% growth
Sakar Healthcare Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue Rs87.4 Cr (+52% YoY), EBITDA Rs24.4 Cr (28% margin), PAT Rs11.3 Cr (+149%); pitch centres on oncology integration.
Sakar Healthcare Results Update
Sakar Healthcare reported Q2 FY27 revenue of ₹87.42 Cr and PAT of ₹11.31 Cr, up 149% YoY. EBITDA rose 114% to ₹24.35 Cr on strong oncology approvals and commercial supply commencement.
Sakar Healthcare Q2 FY27 Results: Net Profit ₹11.3 Cr, Up 151.1% YoY
Sakar Healthcare Ltd reported revenue from operations of ₹87.4 Cr (+51.7% YoY) and net profit of ₹11.3 Cr (+151.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹11.3 Cr · +151.1% YoY
Sakar Healthcare Board Meeting Date
Sakar Healthcare has scheduled a board meeting for October 23, 2026, to approve its unaudited quarterly financial results for the period ended September 2026.
Sakar Healthcare Business Update
Sakar Healthcare says its oncology export model is expanding, with 22 Marketing Authorizations granted and commercial supply starting from its EU GMP site. No monetary value stated.
Other price movement clarification announcements
All →Waaree Energies Price Movement Clarification
Waaree clarifies its 1.2 MTPA green ammonia project in Andhra, confirming government approval. The ₹15,000 Cr investment remains pending internal board approval.
- Value
- ₹15,000 Cr
- green ammonia capacity
- 1.2 MTPA
Bombay Coated and Special Steels Price Movement Clarification
BCSSL replied to NSE's volume-surge query stating no undisclosed material information exists. The company attributes the recent trading activity to market-driven factors.
Tourism Finance Corporation of India Price Movement Clarification
TFCI replied to a BSE query on its rising share volume and price. The company stated all material information is disclosed and the movement is purely market-driven.
Lords Ishwar Hotels Price Movement Clarification
Lords Ishwar Hotels clarified that its GSM Stage 1 inclusion stems from routine exchange surveillance, not any material development. The company affirmed full LODR compliance.
Avantel Price Movement Clarification
Avantel stated no undisclosed information explains the recent volume spurt in its shares. The company attributed the increase to purely market-driven trading activity.
Shakti Pumps (India) Price Movement Clarification
Shakti Pumps confirmed no undisclosed material information behind its volume spurt. The company attributed the movement to market forces and affirmed timely Reg 30 compliance.